<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive Patent License: Radiotherapeutics for Nasopharyngeal Cancer</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive Patent License: Radiotherapeutics for Nasopharyngeal Cancer</h1>
    <p class="timestamp">Published: 2022-10-17 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Molecular Targeting Technologies, Inc. (MTTI); a Delaware corporation, with its principle place of business in West Chester, Pennsylvania, to practice the inventions embodied in the issued patents and patent applications listed in the Supplementary Information section of this notice.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2022-22476</p>
    <p><strong>Publication Date:</strong> 2022-10-17</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2022/10/17/2022-22476/prospective-grant-of-exclusive-patent-license-radiotherapeutics-for-nasopharyngeal-cancer">https://www.federalregister.gov/documents/2022/10/17/2022-22476/prospective-grant-of-exclusive-patent-license-radiotherapeutics-for-nasopharyngeal-cancer</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2022-22476</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
